Discontinued — last reported Q2 '25
Current Assets
Finished goods
Medline, Inc. Finished goods decreased by 1.2% to $3.97B in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2017
Last reportedQ2 2025
Parent metricInventories
How to read this metric
An increase relative to sales may signal slowing demand or overproduction; a decrease may indicate strong sales or supply chain constraints.
Detailed definition
This represents the value of inventory that has completed the manufacturing process and is ready for sale to customers....
Peer comparison
Standard inventory metric for all manufacturing and retail companies.
Metric ID:
inv_finished_goodsHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $4.02B | $3.97B |
| QoQ Change | — | -1.2% |
| % of Inventories | 84.3% | 82.6% |
| Share Change | — | -1.7pp |
Range$3.97B – $4.02B
Finished goods at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's finished goods?
- Medline, Inc. (MDLN) reported finished goods of $3.97B in Q1 2026.
- What does finished goods mean?
- The value of completed products ready for sale.